Bendamustine and Dapsone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bendamustine (bendamustine) and Dapsone (dapsone). Common drug interactions include blood creatinine increased among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Bendamustine and Dapsone. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Bendamustine?

Bendamustine has active ingredients of bendamustine. eHealthMe is studying from 9,508 Bendamustine users. Check the latest studies of Bendamustine.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.



On Jul, 31, 2026

54 people who take Bendamustine and Dapsone together, and have interactions are studied.

Bendamustine and Dapsone drug interactions.

What are the common drug interactions of Bendamustine and Dapsone, by gender? *:

female:

  1. Blood creatinine increased
  2. Hydronephrosis (water inside the kidney)
  3. Cytomegalovirus infection
  4. Diarrhoea
  5. Cytomegalovirus test positive
  6. Blood disorder
  7. Disease progression
  8. Drug intolerance (drug sensitivity)
  9. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  10. Oedema peripheral (superficial swelling)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Leukopenia (less number of white blood cells in blood)
  3. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  4. Ear neoplasm malignant (ear cancerous tumour)
  5. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  6. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  7. Paronychia (infection in the tissues adjacent to a nail on a finger or toe)

What are the common drug interactions of Bendamustine and Dapsone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Leukopenia (less number of white blood cells in blood)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  4. Paronychia (infection in the tissues adjacent to a nail on a finger or toe)

60+:

  1. Abdominal pain
  2. Constipation
  3. Drug intolerance (drug sensitivity)
  4. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  5. Oedema peripheral (superficial swelling)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  8. Ear neoplasm malignant (ear cancerous tumour)
  9. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  10. Upper respiratory tract infection

What are the existing conditions these people have? *

  1. Visual Impairment: 31 people, 57.41%
  2. Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 31 people, 57.41%
  3. Lung Cancer - Non-Small Cell (lung cancer): 31 people, 57.41%
  4. Pain: 27 people, 50.00%
  5. Mucosal Inflammation (infection of mucous membrane): 27 people, 50.00%
  6. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 27 people, 50.00%
  7. Headache (pain in head): 27 people, 50.00%
  8. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 5 people, 9.26%

* Approximation only. Some reports may have incomplete information.

Do you take Bendamustine and Dapsone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bendamustine and Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bendamustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bendamustine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dapsone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on bendamustine and dapsone (the active ingredients of Bendamustine and Dapsone, respectively), and Bendamustine and Dapsone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: